Europe pharmaceutical contract research organization (CRO) market was valued at $12.13 billion in 2021 and will grow by 9.6% annually over 2021-2030, driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity. Highlighted with 69 tables and 48 figures, this 140-page report “Europe Pharmaceutical Contract Research Organization (CRO) Market 2021-2030 by Service, Therap...
Asia Pacific pharmaceutical contract research organization (CRO) market will grow by 11.3% annually with a total addressable market cap of $ 212.8 billion over 2022-2030, driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity. Highlighted with 66 tables and 47 figures, this 139-page report “Asia Pacific Pharmaceutical Contract Research Organization (CRO) Market 2...
Global digital PCR (dPCR) market will reach $ 1,169.9 million by 2031, growing by 11.8% annually over 2021-2031, driven by the rise in prevalence of infectious diseases and cancer, growing awareness & acceptance of personalized medicines, technological advancements in diagnostic tools, and continuous increase in funding for R&D activities. Highlighted with 83 tables and 77 figures, this 157-page report “Global Digital PCR (dPCR) Market 2021-2031 by Offering (Instruments & Accessories, R...
North America digital PCR (dPCR) market is projected to grow by 10.1% annually in the forecast period and reach $ 451.6 million by 2031, driven by the rise in prevalence of infectious diseases and cancer, growing awareness & acceptance of personalized medicines, technological advancements in diagnostic tools, and continuous increase in funding for R&D activities. Highlighted with 22 tables and 46 figures, this 95-page report “North America Digital PCR (dPCR) Market 2021-2031 by Offering...
Europe digital PCR (dPCR) market was valued at $116.4 million in 2021 and will grow by 11.5% annually over 2021-2031, driven by the rise in prevalence of infectious diseases and cancer, growing awareness & acceptance of personalized medicines, technological advancements in diagnostic tools, and continuous increase in funding for R&D activities. Highlighted with 32 tables and 50 figures, this 104-page report “Europe Digital PCR (dPCR) Market 2021-2031 by Offering (Instruments & Accessori...
Asia Pacific digital PCR (dPCR) market will grow by 15.2% annually with a total addressable market cap of $1,699.2 million over 2022-2031, driven by the rise in prevalence of infectious diseases and cancer, growing awareness & acceptance of personalized medicines, technological advancements in diagnostic tools, and continuous increase in funding for R&D activities. Highlighted with 29 tables and 49 figures, this 104-page report “Asia Pacific Digital PCR (dPCR) Market 2021-2031 by Offeri...
Global bioanalytical testing services market will reach $7,902.9 million by 2031, growing by 9.1% annually over 2021-2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach. Highlighted with 88 tables and 111 figures, this 193-page repo...
North America bioanalytical testing services market is projected to grow by 8.3% annually in the forecast period and reach $ 3,232.3 million by 2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach. Highlighted with 29 tables and 75 f...
Europe bioanalytical testing services market was valued at $ 806.6 million in 2021 and will grow by 9.0% annually over 2021-2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach. Highlighted with 39 tables and 79 figures, this 137-pag...
Asia Pacific bioanalytical testing services market will grow by 11.2% annually with a total addressable market cap of $ 13,359.1 million over 2022-2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach. Highlighted with 36 tables and 7...
